REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 23rd, 2018 • Wize Pharma, Inc. • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of October 22, 2018, by and among Wize Pharma, Inc., a Delaware corporation, with headquarters located at 24 Hanagar Street, Hod Hasharon 4527708, Israel (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (each, a “Buyer” and collectively, the “Buyers”).
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • October 23rd, 2018 • Wize Pharma, Inc. • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 23rd, 2018 • Wize Pharma, Inc. • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 22, 2018, by and among Wize Pharma, Inc., a Delaware corporation, with headquarters located at 24 Hanagar Street, POB 6653, Hod Hasharon 4527708, Israel (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
AMENDMENT TO CONVERTILE LOAN AGREEMENTSConvertible Loan Agreement • October 23rd, 2018 • Wize Pharma, Inc. • Pharmaceutical preparations
This Amendment to Convertible Loan Agreements (this “Amendment”) dated this 19th day of October, 2018, by and among Wize Pharma Ltd. Private Company 520033259 (the “Company”), Wize Pharma, Inc., Rimon Gold Assets Ltd., Private Company, 514819424 (“Rimon Gold”), Ridge Valley Corporation (“Ridge Valley”), and Shimshon Fisher (“Fisher”).
